 JUPITER, Fla., Sept. 08, 2022 GLOBE NEWSWIRE -- Dyadic International, Inc. Dyadic, or the Company NASDAQ: DYAI, a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health, today announced that its management and representatives will participate in the following upcoming industry events in September 2022: 